Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
Abstract Simple Summary: Drug resistance is the key factor contributing to the therapeutic failure of lung cancer and the deaths…
Abstract Simple Summary: Drug resistance is the key factor contributing to the therapeutic failure of lung cancer and the deaths…
Abstract Transient receptor potential vanilloid type-2 (TRPV2) is an ion channel that is triggered by agonists like cannabidiol (CBD). Triple…
Abstract The pharmacological importance of cannabinoids has been in study for several years. Cannabinoids comprise of (a) the active compounds…